Live from the NIH registry
Studies recruiting near Youngstown right now
Top 25 of 81 recruiting studies, sorted by proximity — each links to its official registry page
Evaluate the Effects of Citicoline on Mood in Healthy Adults
Healthy
N/A
Interventional 90 participants sought
The Center for Applied Health Sciences — Canfield, Ohio (7.9 mi)
· Sponsor: Kirin Holdings Company, Limited
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Saint Elizabeth Youngstown Hospital — Youngstown, Ohio (0.2 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Decision Algorithm for Vital Sign Assessment in the Outpatient Physical Therapy Setting
Healthy
N/A
Observational 100 participants sought
Youngstown State University — Youngstown, Ohio (0.2 mi)
· Sponsor: Youngstown State University
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Saint Elizabeth Youngstown Hospital — Youngstown, Ohio (0.2 mi)
· Sponsor: SWOG Cancer Research Network
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 2,400 participants sought
Saint Elizabeth Youngstown Hospital — Youngstown, Ohio (0.2 mi)
· Sponsor: SWOG Cancer Research Network
Pip Care to Improve Surgical Patient Outcomes
Abdominal Surgery
N/A
Interventional 900 participants sought
UPMC Jameson Hospital — New Castle, Pennsylvania (16.9 mi)
· Sponsor: University of Pittsburgh
Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Knee
Osteoarthritis
Phase 2
Interventional 4,000 participants sought
VivaTech International, Inc. — Grove City, Pennsylvania (29.3 mi)
· Sponsor: VivaTech International, Inc.
Effects of Miricell Supplementation on Biomarkers of Healthy Aging and Autophagy
Autophagy, Healthy Aging
N/A
Interventional 70 participants sought
The Center for Applied Health Sciences — Canfield, Ohio (7.9 mi)
· Sponsor: Nutraland USA, Inc.
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
UPMC Cancer Center at UPMC Horizon — Farrell, Pennsylvania (11.0 mi)
· Sponsor: National Cancer Institute (NCI)
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
Atopic Dermatitis
Phase 2
Interventional 350 participants sought
Investigational Site — Boardman, Ohio (5.3 mi)
· Sponsor: Apogee Therapeutics, Inc.
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Phase 3
Interventional 1,100 participants sought
Saint Elizabeth Youngstown Hospital — Youngstown, Ohio (0.2 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
Colorectal Cancer, CRC (Colorectal Cancer)
Phase 2
Interventional 136 participants sought
NGM Clinical Study Site — Youngstown, Ohio (0.2 mi)
· Sponsor: NGM Biopharmaceuticals, Inc
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma
Phase 3
Interventional 269 participants sought
Saint Elizabeth Youngstown Hospital — Youngstown, Ohio (0.2 mi)
· Sponsor: NRG Oncology
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 1,524 participants sought
UPMC Cancer Center at UPMC Horizon — Farrell, Pennsylvania (11.0 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
Saint Elizabeth Youngstown Hospital — Youngstown, Ohio (0.2 mi)
· Sponsor: SWOG Cancer Research Network
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Advanced Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma
Phase 2
Interventional 46 participants sought
Saint Elizabeth Youngstown Hospital — Youngstown, Ohio (0.2 mi)
· Sponsor: National Cancer Institute (NCI)
Phase 2/3 Efficacy and Safety of PP405 in Adult Males
Androgenetic Alopecia
Phase 2, Phase 3
Interventional 600 participants sought
Optima Research Boardman — Boardman, Ohio (5.3 mi)
· Sponsor: Pelage Pharmaceuticals, Inc.
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Multiple conditions
Phase 2
Interventional 314 participants sought
Saint Elizabeth Youngstown Hospital — Youngstown, Ohio (0.2 mi)
· Sponsor: National Cancer Institute (NCI)
The Lilac Device Trial - IMPACT: A Clinical Investigation on IMproving Peripheral Neuropathy Induced by Chemotherapy With Advanced Compression Technology - A Safety and Efficacy Study
Chemotherapy Induced Peripheral Neuropathy (CIPN)
N/A
Interventional 142 participants sought
Mercy Health St. Elizabeth Hospital — Youngstown, Ohio (0.2 mi)
· Sponsor: Luminate Medical, Inc.
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery
Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7, Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7
Phase 2
Interventional 82 participants sought
UPMC Jameson — New Castle, Pennsylvania (16.9 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Breast Cancer, Early Breast Cancer
Phase 3
Interventional 5,500 participants sought
Research Site — Youngstown, Ohio (0.2 mi)
· Sponsor: AstraZeneca
a Prospective, Multicenter, Randomized Controlled Trial, With a Non-randomized Sentinel Cohort, Evaluating the Efficacy of Bioxheal, a Single-layer Placental-derived Biologic in Nonhealing Diabetic Foot Ulcers
Diabetic Foot Ulcer, Amniotic Membrane Placental Allograft
Phase 3
Interventional 253 participants sought
NOMS Ankle and Foot Care Center — Boardman, Ohio (5.3 mi)
· Sponsor: Applied Biologics, LLC
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 188 participants sought
UPMC Cancer Center at UPMC Horizon — Farrell, Pennsylvania (11.0 mi)
· Sponsor: National Cancer Institute (NCI)
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
Buccal Mucosa Squamous Cell Carcinoma, Floor of Mouth Squamous Cell Carcinoma
Phase 2, Phase 3
Interventional 686 participants sought
UPMC Cancer Center at UPMC Horizon — Farrell, Pennsylvania (11.0 mi)
· Sponsor: NRG Oncology
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
Pruritus
Phase 3
Interventional 284 participants sought
Optima Research - Boardman- Site Number : 8400039 — Boardman, Ohio (5.3 mi)
· Sponsor: Sanofi